 |
|
|
|
|
|
|
|
|
|
|
|
1 to 30 of 30 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Muresan Z, Muresan V. on PAPER: Yoon SO. et al., 2012, The mechanisms that lead to the pathology of Alzheimer’s disease (AD) are not completely... 14 Sep 2012.
|
|
|
 |
|
|
Muresan Z, Muresan V, Villegas C. on NEWS: Coming Into Vogue? Retromer in APP Processing, AD Pathogenesis, The three recent papers discussed here (1-3) shed new light on the role of retromer in... 12 Jul 2012.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Marinkovic P. et al., 2012, The mechanisms that lead to synaptic failure, neuronal degeneration, and—finally—neuronal death... 2 Mar 2012.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Tampellini D. et al., 2011, Aside from findings related to the intraneuronal accumulation of Aβ in the Alzheimer’s disease... 23 Dec 2011.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Matrone C. et al., 2011, This study by Matrone et al. establishes a reciprocal, functional link between the... 3 Oct 2011.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Ranganathan S. et al., 2011, There is no question that the complex processing of amyloid-β precursor protein (APP), via at... 3 Aug 2011.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Winton MJ. et al., 2011, We would like to comment on a few issues raised by this paper and previous comments, starting... 13 Jun 2011.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Bero AW. et al., 2011, The Alzforum recently hosted a vivid Webinar that—among others—challenged the absolute supremacy... 12 May 2011.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Braak H. et al., 2011, In this paper, Braak and Del Tredici propose that the Alzheimer’s disease (AD) process may not... 4 May 2011.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Cheng SB. et al., 2011, Whether abnormal axonal transport is a cause or a consequence of the neuronal pathology in... 21 Apr 2011.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Encalada SE. et al., 2011, With their recent paper on the transport of prion protein-containing vesicles, Encalada and her... 2 Mar 2011.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Tampellini D. et al., 2010, We commend Gunnar Gouras for persevering with his studies on intraneuronal amyloid-β (Aβ).... 26 Jan 2011.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Herrup K. et al., 2010, Karl Herrup got it right with his novel hypothesis on Alzheimer’s disease (AD). The two main... 14 Jan 2011.
|
|
|
|
|
|
Muresan Z, Muresan V. on NEWS: Insidious Spread of Aβ: More Support for Synaptic Transmission, The paper by Harris et al. is right on target with regard to the nucleation of plaques by seeds... 10 Nov 2010.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Li H. et al., 2010, This interesting paper from Hui Zheng’s lab reminds us that there is still much to learn about... 27 Sep 2010.
|
|
|
|
|
|
Muresan Z, Muresan V. on NEWS: Lilly Halts IDENTITY Trials as Patients Worsen on Secretase Inhibitor, Much was talked about in the past month after the announcement of the apparent failure of the... 22 Sep 2010.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Decker H. et al., 2010, We intended to comment on this interesting paper from the Silverman lab prior to leaving for... 25 Jul 2010.
|
|
|
|
|
|
Muresan Z, Muresan V. on NEWS: Inside Out—Plaques May Have Intracellular Origin, Two papers published recently in PNAS (1,2) touch an issue close to our hearts: the nucleation... 28 Jan 2010.
|
|
|
|
|
|
Muresan Z, Muresan V. on NEWS: APP in Pieces: βCTF implicated in Endosome Dysfunction, It is established that overexpression of APP, such as in Down syndrome, leads to endosome... 26 Jan 2010.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Rohe M. et al., 2009, We would like to comment on two aspects raised by the interesting paper by Rohe et al. (1),... 23 Dec 2009.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Szodorai A. et al., 2009, We read this paper by Szodorai et al. and found it interesting, especially with regard to the... 20 Nov 2009.
|
|
|
|
|
|
Muresan Z, Muresan V. on NEWS: Reelin, Aβ, α7 Play Yin and Yang Around NMDA Receptors, The three papers [1-3] discussed in this Research News are highly relevant for the pathogenic... 11 Sep 2009.
|
|
|
|
|
|
Muresan Z, Muresan V. on PAPER: Perlson E. et al., 2009, The paper by Perlson et al. brings to our attention the important issue of the contribution of... 25 Aug 2009.
|
|
|
|
|
|
Muresan Z, Muresan V. on NEWS: Aβ the Bad Apple? Seeding and Propagating Amyloidosis, The paper by Eisele et al. (1) convincingly shows that minute amounts of Aβ-containing brain... 5 Aug 2009.
|
|
|
|
|
|
Muresan Z, Muresan V. on NEWS: Huntingtin—Putting the Boot on Axonal Transport, We would like to comment on the interesting results of the recent study by Morfini et al. (1).... 14 Jul 2009.
|
|
|
|
|
|
Muresan Z, Muresan V. on NEWS: Divorce Protein Style—APP Fragments Go Their Own Way in Cells, We read with great interest the paper by Liu et al. (1), and would like to comment on their... 9 Apr 2009.
|
|
|
|
|
|
Muresan Z, Muresan V. on NEWS: Neuron Loss in AD Mouse—Yes, But Not the Cholinergic Kind, It was gratifying to read the paper by Liu et al. [1], at a time when our hypothesis on the... 29 Dec 2008.
|
|
|
|
|
|
Muresan Z, Muresan V. on NEWS: New Role for p25/Cdk5 in Regulation of BACE Expression, We would like to comment on the interesting article by Wen et al. [1] on triggering BACE1 gene... 1 Apr 2008.
|
|
|
|
|
|
Muresan Z, Muresan V. on NEWS: San Diego: Oligomers Live Up to Bad Reputation, Part 1, We have read with great interest all the recent reports and comments on the toxicity of Aβ... 20 Dec 2007.
|
|
|
|
|
|
Muresan V. on LIVE DISCUSSION: APP Family: Clues to Function in Health and AD
, Yes, this is a great question: "Does APP have a function of its own (i.e., as a full-length... 11 Oct 2007.
|
|
|
|
|
|
|
1 to 30 of 30 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
